Swiss pharmaceutical giant Roche recently announced a $425 million acquisition of GeneveAVE BioSciences, an in vitro diagnostic company, and a final agreement has been reached. Roche will pay a $190 million advance payment and a related milestone totaling $235 million. Roche said that GeneWEAVE's innovative Smarticles technology will further strengthen Roche's position in the field of microbiology diagnostics. Upon completion of the acquisition, GeneWEAVE will be integrated into Roche Molecular Diagnostics. GeneWEAVE is a privately held in vitro diagnostic company based in California, USA, dedicated to advancing the development of innovative clinical microbiological diagnostic solutions to help healthcare providers deliver effective resistance surveillance, early treatment guidance, and success. Antibiotic management to address the problem of resistant bacteria. . GeneWEAVE's proprietary Smarticles technology is an innovative molecular diagnostic technology that quickly identifies multidrug-resistant bacteria (MDROs) while assessing the sensitivity of antibiotics directly from clinical samples without the need for traditional enrichment or sample preparation. . The first system developed by GeneWEAVE is vivoDx, a fully automated random access system designed to meet the needs of the laboratory to address MDRO and antibiotic treatment guidelines, which are currently being evaluated at multiple clinical sites in the United States. Roland Diggelmann, chief operating officer of Roche Diagnostics, said that the acquisition of the cutting-edge technology of Smarticles by GeneWEAVE will further strengthen Roche's position in the field of microbial diagnosis and will help to cope with the increasingly severe problem of super-resistant bacteria. This technology will enable healthcare professionals to obtain fast and accurate diagnoses to support fast and correct treatment decisions. As a professional supplier of medical apparatuses and instruments, Suzhou Medtion International Trade Co., Ltd. is located in Zhangjiagang City, Jiangsu Province. We are wholly owned subsidiary of Jiangsu Redleaf Medcial Equipment Co., Ltd who is a professional Medical equipment producer for 30 years. We specialize in developing and producing stretchers,anti-coronavirus products, first-aid product, Funeral Products, ward products, Diagnosis Device, emergency rescue product and so on. We supply one stop purchasing of Medical Equipment for all overseas customers. Our products can be made in accordance with customers' requirements. With advanced technology, scientific production equipment, reliable product's quality, conform contract, stable credit and excellent service, we have got the production aptitude and passed all quality authentications successfully. We warmly welcome you to cooperate with us. Operation Room Equipment,Medical Binocular Magnifier,Operation Bed,Operation Instrument Medton Medical , https://www.medtonmedical.com